New Flomaquine Overseas
New Flomaquine Overseas reported total assets of 409 € at the end of the 2017 financial year (annual accounts filed with the NBB on 25 Sep 2018).
The score of New Flomaquine Overseas shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2017
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
New Flomaquine Overseas's annual accounts
| 2017 | |
|---|---|
| Net result | −3,219 € |
| Equity | −3,219 € |
| Cash | 5 € |
| EBITDA | −3,172 € |
| Total assets | 409 € |
Filed annual accounts
- Year ended 31 Dec 2017filed on 25 Sep 2018
New Flomaquine Overseas's financial analysis
Management and control of New Flomaquine Overseas
New Flomaquine Overseas's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0677.417.316
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Incorporated
- 21 Jun 2017
- Registered office
- 1180 Uccle
- Latest accounts
- 2017 · filed on 25 Sep 2018
- Activity
- Manufacture of medicaments (NACE 21201)
New Flomaquine Overseas has been based in Uccle since 2017, active in: manufacture of medicaments. For 2017, it reports a net loss of 3,219 € and equity of −3,219 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to New Flomaquine Overseas
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Fortilab Distribution and Promotion Manufacture of pharmaceutical preparations Etterbeek · balance sheet 118,838 €
- Mythralica Manufacture of pharmaceutical preparations Etterbeek · balance sheet 135,553 €
- SH Medlab Manufacture of pharmaceutical preparations Brussels · balance sheet 249,728 €
- Parc Elisabeth Pharma Manufacture of pharmaceutical preparations Ganshoren · balance sheet 296,304 €
- Prieka Manufacture of pharmaceutical preparations Etterbeek · balance sheet 440,325 €
- Laboratoires Sopreli Manufacture of pharmaceutical preparations Anderlecht · balance sheet €1.10m
- Fortilab Manufacture of pharmaceutical preparations Etterbeek · balance sheet €1.39m
Frequently asked questions about New Flomaquine Overseas
What is the revenue of New Flomaquine Overseas?
New Flomaquine Overseas files its accounts in a format where revenue is optional: it is not published for 2017.
What is the VAT number of New Flomaquine Overseas?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for New Flomaquine Overseas. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0677417316. Its company number (CBE) is 0677.417.316.
Where is the registered office of New Flomaquine Overseas?
According to the CBE register, the registered office of New Flomaquine Overseas is in 1180 Uccle.
Who manages New Flomaquine Overseas?
The register lists 1 active mandates at New Flomaquine Overseas. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of New Flomaquine Overseas
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →